3 results
Approved WMORecruiting
The goal of this registry study is to provide insight in the safety and efficacy of treatment with MOCA for primary insufficiency of the GSV with a diameter >/=12mm, insufficient antero-lateral branches (<12 mm) and insifficincy of the…
Approved WMOCompleted
To determine the activity (as measured by objective response rate by RECIST1.1) of monalizumab and trastuzumab in patients with metastatic HER2-positive breast cancer.
Approved WMOPending
NMOSD is associated with a high degree of disability and mortality, and there is a unmet medical need in children with this disease.Results from the pivotal study (Study CD-IA-MEDI-551-1155) in adult patients with NMOSD demonstrated a 77% reduction…